Advanced Cell Diagnostics Raises $12M in Series B Round | GenomeWeb

NEW YORK (GenomeWeb News) – Advanced Cell Diagnostics today said that it completed its $12 million Series B equity financing round to support the commercial expansion of its RNA biomarker technology.

New Leaf Venture Partners and existing investor Morningside Ventures participated in the round.

The funding will go toward further commercialization of Advanced Cell's RNAscope-based products and services into the life science research market, as well as toward acceleration of RNAscope into the clinical diagnostics space.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.